Case Study by TWi Biotechnology: Use of Tofacitinib Citrate Gel in the Treatment of Atopic Dermatitis and Vitiligo

Time: 1:45 pm
day: Day Two

Details:

• What is the role of tofacitinib, a JAK1/3 inhibitor, in pro-inflammatory cytokine pathways in immunological skin diseases?
• Investigating the clinical development of topical tofacitinib using drug repurposing strategy
• Reviewing tofacitinib efficacy results in recent clinical studies in atopic dermatitis and vitiligo

Speakers: